{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:20:06Z","timestamp":1790644806229,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.actbio.2013.10.015","type":"journal-article","created":{"date-parts":[[2013,10,19]],"date-time":"2013-10-19T11:45:37Z","timestamp":1382183137000},"page":"688-700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["New stent surface materials: The impact of polymer-dependent interactions of human endothelial cells, smooth muscle cells, and platelets"],"prefix":"10.1016","volume":"10","author":[{"given":"Raila","family":"Busch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Strohbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Rethfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Walz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5559-7030","authenticated-orcid":false,"given":"Mathias","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6482-3204","authenticated-orcid":false,"given":"Svea","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Felix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Sternberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2013.10.015_b0005","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jacc.2007.06.029","article-title":"Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial","volume":"50","author":"Morice","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.actbio.2013.10.015_b0010","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacc.2010.06.007","article-title":"Coronary stents: current status","volume":"56","author":"Garg","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.actbio.2013.10.015_b0015","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1161\/01.CIR.0000034045.36219.12","article-title":"Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size","volume":"106","author":"Regar","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.actbio.2013.10.015_b0020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/eurheartj\/ehp424","article-title":"Safety and efficacy of drug-eluting vs. bare metal stents in patients with diabetes mellitus: long-term follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)","volume":"31","author":"Stenestrand","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.actbio.2013.10.015_b0025","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1161\/01.CIR.98.18.1875","article-title":"Vessel size and long-term outcome after coronary stent placement","volume":"98","author":"Elezi","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.actbio.2013.10.015_b0030","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2174\/156720111796642282","article-title":"Local delivery of therapeutics for percutaneous coronary intervention","volume":"8","author":"Kennedy","year":"2011","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.actbio.2013.10.015_b0035","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejpb.2010.12.021","article-title":"Examination of drug release and distribution from drug-eluting stents with a vessel-simulating flow-through cell","volume":"78","author":"Seidlitz","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.actbio.2013.10.015_b0040","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/ccd.23062","article-title":"A comparative analysis of major clinical outcomes using drug-eluting stents versus bare metal stents in diabetic versus nondiabetic patients","volume":"78","author":"Regar","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.actbio.2013.10.015_b0045","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1080\/14628840500466687","article-title":"Drug-eluting stents for the treatment of in-stent restenosis\u2013'real world' double centre experience in consecutive patients","volume":"7","author":"Anderson","year":"2005","journal-title":"Int J Cardiovasc Intervent."},{"key":"10.1016\/j.actbio.2013.10.015_b0050","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4244\/EIJV7I1A14","article-title":"Predictors of death or myocardial infarction, ischaemic-driven revascularisation, and major adverse cardiovascular events following everolimus-eluting or paclitaxel-eluting stent deployment: pooled analysis from the SPIRIT II, III, IV and COMPARE trials","volume":"7","author":"Kereiakes","year":"2011","journal-title":"EuroIntervention"},{"key":"10.1016\/j.actbio.2013.10.015_b0055","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jcin.2010.08.003","volume":"3","author":"Simsek","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.actbio.2013.10.015_b0060","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(07)60314-6","article-title":"Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study","volume":"369","author":"Daemen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.actbio.2013.10.015_b0065","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00059-008-3080-x","article-title":"Drug-eluting coronary stent very late thrombosis revisited","volume":"33","author":"Lanzer","year":"2008","journal-title":"Herz"},{"key":"10.1016\/j.actbio.2013.10.015_b0070","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jacc.2005.07.071","article-title":"Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project","volume":"47","author":"Nebeker","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.actbio.2013.10.015_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.cjca.2013.04.001","article-title":"Late and very late stent thrombosis in patients with second-generation drug-eluting stents","author":"Huang","year":"2013","journal-title":"Can J Cardiol"},{"issue":"8","key":"10.1016\/j.actbio.2013.10.015_b0080","first-page":"1092","article-title":"Safety and efficacy outcomes of overlapping second-generation everolimus-eluting stents versus first-generation drug-eluting stents","volume":"111","author":"Kitabata","year":"2013","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.actbio.2013.10.015_b0085","first-page":"330","article-title":"Stent thrombosis with second- versus first-generation drug-eluting stents in real-world percutaneous coronary intervention: analysis of 3806 consecutive procedures from a large-volume single-center prospective registry","volume":"25","author":"Dores","year":"2013","journal-title":"J Invasive Cardiol"},{"issue":"2","key":"10.1016\/j.actbio.2013.10.015_b0090","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ahj.2013.04.014","article-title":"Study design and rationale of \u201cA Multicenter, Open-Labeled, Randomized Controlled Trial Comparing Three 2nd-Generation Drug-Eluting Stents in Real-World Practice\u201d (CHOICE trial)","volume":"166","author":"Youn","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.actbio.2013.10.015_b0095","first-page":"733","article-title":"Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions","volume":"44","author":"Kipshidze","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.actbio.2013.10.015_b0100","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1016\/j.biomaterials.2010.02.003","article-title":"In vitro and in vivo changes to PLGA\/sirolimus coating on drug eluting stents","volume":"31","author":"Xi","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2013.10.015_b0105","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1583\/06-1899R.1","article-title":"Iliac anastomotic stenting with a sirolimus-eluting biodegradable poly-l-lactide stent: a preliminary study after 6 weeks","volume":"13","author":"B\u00fcnger","year":"2006","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.actbio.2013.10.015_b0110","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s10856-007-0148-8","article-title":"In vitro study of drug-eluting stent coatings based on poly(l-lactide) incorporating cyclosporine A\u2014drug release, polymer degradation and mechanical integrity","volume":"18","author":"Sternberg","year":"2007","journal-title":"J Mater Sci \u2013 Mater Med"},{"key":"10.1016\/j.actbio.2013.10.015_b0115","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/ccd.20926","article-title":"Effectiveness and safety of the sirolimus-eluting stents coated with bioabsorbable polymer coating in human coronary arteries","volume":"69","author":"Ge","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.actbio.2013.10.015_b0120","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.4244\/EIJV7I9A168","article-title":"Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial","volume":"7","author":"Dudek","year":"2012","journal-title":"EuroIntervention"},{"key":"10.1016\/j.actbio.2013.10.015_b0125","doi-asserted-by":"crossref","first-page":"5689","DOI":"10.1166\/jnn.2011.4496","article-title":"Development of a biodegradable sirolimus-eluting stent coated by ultrasonic atomizing spray","volume":"11","author":"Kim","year":"2011","journal-title":"J Nanosci Nanotechnol"},{"key":"10.1016\/j.actbio.2013.10.015_b0130","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/ccd.20895","article-title":"First-in-human implantation of a fully bioabsorbable drug-eluting stent: the BVS poly-l-lactic acid everolimus-eluting coronary stent","volume":"69","author":"Ormiston","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.actbio.2013.10.015_b0135","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.jacc.2011.05.050","article-title":"Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes","volume":"58","author":"Serruys","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.actbio.2013.10.015_b0140","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1586\/17434440.3.6.853","article-title":"Biomedical applications of polyhydroxyalkanoates: an overview of animal testing and in vivo responses","volume":"3","author":"Valappil","year":"2006","journal-title":"Expert Rev Med Devices"},{"key":"10.1016\/j.actbio.2013.10.015_b0145","first-page":"1","article-title":"Absorbable polymer stent technologies for vascular regeneration","volume":"85","author":"Grabow","year":"2010","journal-title":"J Chem Technol Biotechnol"},{"key":"10.1016\/j.actbio.2013.10.015_b0150","first-page":"503","article-title":"Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells","volume":"58","author":"Jantzen","year":"2007","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.actbio.2013.10.015_b0155","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrcardio.2011.148","article-title":"Restenosis after PCI. Part 2: prevention and therapy","volume":"9","author":"Jukema","year":"2012","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.actbio.2013.10.015_b0160","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2010.06.008","article-title":"Coronary stents: looking forward","volume":"56","author":"Garg","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.actbio.2013.10.015_b0165","first-page":"567","article-title":"Polymer coatings and delayed arterial healing following drug-eluting stent implantation","volume":"57","author":"Byrne","year":"2009","journal-title":"Minerva Cardioangiol"},{"key":"10.1016\/j.actbio.2013.10.015_b0170","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1540-8183.2009.00423.x","article-title":"Passive and active polymer coatings for intracoronary stents: novel devices to promote arterial healing","volume":"22","author":"Pendyala","year":"2009","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.actbio.2013.10.015_b0175","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.ehj.2004.06.010","article-title":"Long-term assessment of a novel biodegradable paclitaxel-eluting coronary polylactide stent","volume":"25","author":"Vogt","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.actbio.2013.10.015_b0180","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4137\/CMC.S11516","article-title":"Second generation drug-eluting stents: a review of the everolimus-eluting platform","volume":"7","author":"Whitbeck","year":"2013","journal-title":"Clin Med Insights Cardiol"},{"issue":"9","key":"10.1016\/j.actbio.2013.10.015_b0185","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.4244\/EIJV8I9A161","article-title":"Five-year long-term clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery disease: the SPIRIT II trial","volume":"8","author":"Onuma","year":"2013","journal-title":"EuroIntervention"},{"key":"10.1016\/j.actbio.2013.10.015_b0190","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.jacc.2007.02.059","article-title":"Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior","volume":"49","author":"Chatzizisis","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.actbio.2013.10.015_b0195","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1253\/circj.CJ-11-0366","article-title":"Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy","volume":"75","author":"Curcio","year":"2011","journal-title":"Circ J"},{"key":"10.1016\/j.actbio.2013.10.015_b0200","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1161\/CIRCULATIONAHA.107.693739","article-title":"Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialisation","volume":"115","author":"Finn","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.actbio.2013.10.015_b0205","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00424-007-0212-8","article-title":"The endothelial glycocalyx: composition, functions, and visualization","volume":"454","author":"Reitsma","year":"2007","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.actbio.2013.10.015_b0210","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2796.2006.01625.x","article-title":"Vasculoprotective properties of the endothelial glycocalyx: effects of fluid shear stress","volume":"259","author":"Gouverneur","year":"2006","journal-title":"J Intern Med"},{"key":"10.1016\/j.actbio.2013.10.015_b0215","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1039\/B312189E","article-title":"Observation and characterisation of the glycocalyx of viable human endothelial cells using confocal laser scanning microscopy","volume":"6","author":"Barker","year":"2004","journal-title":"Phys Chem Chem Phys"},{"key":"10.1016\/j.actbio.2013.10.015_b0220","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/01.mol.0000181325.08926.9c","article-title":"The endothelial glycocalyx: a potential barrier between health and vascular disease","volume":"16","author":"Nieuwdorp","year":"2005","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.actbio.2013.10.015_b0225","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/01.ATV.0000125114.88079.96","article-title":"Dysfunction of endothelial nitric oxide synthase and atherosclerosis","volume":"24","author":"Kawashima","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.actbio.2013.10.015_b0230","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/01.ATV.21.2.201","article-title":"Endothelial NO synthase overexpression inhibits lesion formation in mouse model of vascular remodeling","volume":"21","author":"Kawashima","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.actbio.2013.10.015_b0235","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2796.2006.01623.x","article-title":"Platelet endothelial cell adhesion molecule-1 and mechanotransduction in vascular endothelial cells","volume":"259","author":"Fujiwara","year":"2006","journal-title":"J Intern Med"},{"key":"10.1016\/j.actbio.2013.10.015_b0240","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0006-291X(02)02982-0","article-title":"Platelet-endothelial cell adhesion molecule-1 modulates endothelial migration through its immunoreceptor tyrosine-based inhibitory motif","volume":"301","author":"Gratzinger","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.actbio.2013.10.015_b0245","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1177\/153537020222600715","article-title":"Regulation of PECAM-1 in endothelial cells during cell growth and migration","volume":"226","author":"RayChaudhury","year":"2001","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.actbio.2013.10.015_b0250","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1242\/jcs.02541","article-title":"Role of PECAM-1 in the shear-stress-induced activation of Akt and the endothelial nitric oxide synthase (eNOS) in endothelial cells","volume":"118","author":"Fleming","year":"2005","journal-title":"J Cell Sci"},{"issue":"7","key":"10.1016\/j.actbio.2013.10.015_b0255","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1056\/NEJMra0910283","article-title":"Hypoxia and inflammation","volume":"364","author":"Eltzschig","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.actbio.2013.10.015_b0260","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.tcm.2008.01.006","article-title":"Neutrophils as sources of extracellular nucleotides: functional consequences at the vascular interface","volume":"18","author":"Eltzschig","year":"2008","journal-title":"Trends Cardiovasc Med"},{"issue":"7","key":"10.1016\/j.actbio.2013.10.015_b0265","doi-asserted-by":"crossref","first-page":"e2801","DOI":"10.1371\/journal.pone.0002801","article-title":"ATP release from vascular endothelia occurs across Cx43 hemichannels and is attenuated during hypoxia","volume":"3","author":"Faigle","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.actbio.2013.10.015_b0270","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood-2010-04-278812","article-title":"Intracoronary shear-related up-regulation of platelet P-selectin and platelet-monocyte aggregation despite the use of aspirin and clopidogrel","volume":"117","author":"Yong","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.actbio.2013.10.015_b0275","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.thromres.2010.11.021","article-title":"The effect of physiologically relevant dynamic shear stress on platelet and endothelial cell activation","volume":"127","author":"Yin","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.actbio.2013.10.015_b0280","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1016\/j.biomaterials.2011.04.067","article-title":"Platelet inhibition and endothelial cell adhesion on elastin-like polypeptide surface modified materials","volume":"32","author":"Blit","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2013.10.015_b0285","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/194927b0","article-title":"Aggregation of blood platelets by adenosine diphosphate and its reversal","volume":"194","author":"Born","year":"1962","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2013.10.015_b0290","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0049-3848(01)00249-3","article-title":"Effect of gamma-hydroxybutyric acid on human platelet aggregation in vitro","volume":"102","author":"Franconi","year":"2001","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.actbio.2013.10.015_b0295","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S0735-1097(96)00584-0","article-title":"Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model","volume":"29","author":"Lincoff","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.actbio.2013.10.015_b0300","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s10439-007-9376-9","article-title":"A biodegradable slotted tube stent based on poly(l-lactide) and poly(4-hydroxybutyrate) for rapid balloon-expansion","volume":"35","author":"Grabow","year":"2007","journal-title":"Ann Biomed Eng"},{"key":"10.1016\/j.actbio.2013.10.015_b0305","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa067193","article-title":"Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents","volume":"356","author":"Stone","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.actbio.2013.10.015_b0310","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk","volume":"48","author":"Joner","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.actbio.2013.10.015_b0315","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/eurheartj\/ehi571","article-title":"Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation","volume":"27","author":"Hofma","year":"2006","journal-title":"Eur Heart J"}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706113005230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706113005230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T21:06:43Z","timestamp":1564520803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706113005230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S1742706113005230"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2013.10.015","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New stent surface materials: The impact of polymer-dependent interactions of human endothelial cells, smooth muscle cells, and platelets","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2013.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}